Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens
US5955508A · kind A · utility
1Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1996 |
| Grant date | Sep 21, 1999 |
| Priority date | — |
| Expiry date | Oct 15, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the treatment of an immunocompromised human, e.g., an AIDS or HIV positive patient, for the enhancement of lymphocyte activity against opportunistic microbial pathogens or the treatment of any human for the enhancement of lymphocyte activity against tumors using a lymphocyte-activity-enhancing amount of dextrofenfluramine or a pharmaceutically-acceptable acid addition salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.